V Wealth Advisors LLC increased its position in shares of Cerner Co. (NASDAQ:CERN) by 1.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 21,138 shares of the company’s stock after acquiring an additional 252 shares during the quarter. V Wealth Advisors LLC’s holdings in Cerner were worth $1,544,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently modified their holdings of the company. BlackRock Inc. lifted its stake in Cerner by 8.4% in the first quarter. BlackRock Inc. now owns 23,927,386 shares of the company’s stock valued at $1,368,887,000 after buying an additional 1,848,617 shares during the period. Parnassus Investments CA lifted its stake in Cerner by 15.6% in the first quarter. Parnassus Investments CA now owns 11,361,322 shares of the company’s stock valued at $649,981,000 after buying an additional 1,531,499 shares during the period. MERIAN GLOBAL INVESTORS UK Ltd lifted its stake in Cerner by 25.7% in the first quarter. MERIAN GLOBAL INVESTORS UK Ltd now owns 3,324,449 shares of the company’s stock valued at $190,191,000 after buying an additional 680,664 shares during the period. Confluence Investment Management LLC acquired a new position in Cerner in the first quarter valued at about $26,070,000. Finally, Geode Capital Management LLC lifted its stake in Cerner by 7.8% in the fourth quarter. Geode Capital Management LLC now owns 4,747,793 shares of the company’s stock valued at $248,593,000 after buying an additional 342,029 shares during the period. 83.05% of the stock is currently owned by institutional investors and hedge funds.
Shares of NASDAQ:CERN traded up $0.13 during mid-day trading on Friday, reaching $71.62. 64,873 shares of the stock were exchanged, compared to its average volume of 2,316,573. The company has a current ratio of 2.52, a quick ratio of 2.50 and a debt-to-equity ratio of 0.22. The company has a market capitalization of $22.69 billion, a P/E ratio of 32.30, a P/E/G ratio of 2.02 and a beta of 0.92. Cerner Co. has a one year low of $48.78 and a one year high of $76.47. The business’s 50 day moving average price is $73.14.
The company also recently disclosed a special dividend, which was paid on Friday, July 26th. Investors of record on Tuesday, June 18th were issued a dividend of $0.18 per share. The ex-dividend date of this dividend was Monday, June 17th. Cerner’s payout ratio is presently 32.58%.
Several equities analysts have weighed in on CERN shares. ValuEngine raised Cerner from a “hold” rating to a “buy” rating in a research note on Wednesday, May 1st. Cantor Fitzgerald increased their price target on Cerner from $75.00 to $85.00 and gave the stock an “overweight” rating in a report on Monday, July 8th. Wells Fargo & Co increased their price target on Cerner from $72.00 to $80.00 and gave the stock an “outperform” rating in a report on Thursday, July 25th. Piper Jaffray Companies increased their price target on Cerner from $74.00 to $80.00 and gave the stock an “overweight” rating in a report on Thursday, July 25th. Finally, Zacks Investment Research downgraded Cerner from a “buy” rating to a “hold” rating and set a $77.00 price target for the company. in a report on Monday, July 29th. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and eleven have assigned a buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $73.36.
In other Cerner news, Director William D. Zollars sold 1,400 shares of the firm’s stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $72.11, for a total value of $100,954.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Randy D. Sims sold 48,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $69.27, for a total value of $3,324,960.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 441,468 shares of company stock valued at $30,777,997. 0.75% of the stock is owned by corporate insiders.
Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Recommended Story: What are catch-up contributions?
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.